Skip to main content
Advertisement
GLP-1 Claims — Maine

Ozempic & GLP-1 Lawsuit in Maine

Last Updated: April 1, 2026

Maine offers one of the most generous statutes of limitations in the nation at six years for both personal injury and product liability claims, providing substantial time for residents to discover and pursue Depo-Provera and GLP-1 medication injury cases. This extended filing window is particularly beneficial given Maine's rural character and aging population, where medical diagnoses may be delayed. The state's single federal district handles all pharmaceutical litigation from its court in Portland.

GLP-1 medications including Ozempic, Wegovy, Mounjaro, and Trulicity have been linked to serious injuries including gastroparesis, vision loss (NAION), pancreatitis, gallbladder disease, and bowel obstruction. Over 3,400 lawsuits are pending in federal court. Maine residents who were injured may qualify for compensation. The product liability statute of limitations in Maine is 6 years. Attorneys handle these cases on a contingency fee basis — no cost unless you win.

The Litigation

GLP-1 Medication Lawsuits in Maine

GLP-1 receptor agonist medications — including Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, and Trulicity — were prescribed to millions of Maine residents for type 2 diabetes and weight management. While these drugs were marketed as breakthrough treatments, growing evidence has linked them to severe and sometimes permanent injuries that the manufacturers allegedly failed to adequately disclose.

The federal litigation against Novo Nordisk and Eli Lilly has been consolidated into multidistrict litigation (MDL 3094) in the Eastern District of Pennsylvania. Maine residents who suffered injuries from GLP-1 medications can file claims that join this consolidated proceeding, benefiting from coordinated pretrial discovery while retaining their individual right to trial.

The lawsuits allege that the manufacturers knew their drugs could cause serious gastrointestinal injuries — including stomach paralysis, bowel blockages, and pancreatic inflammation — as well as vision loss, yet they prioritized profits over patient safety by failing to warn prescribers and patients about the true scope of these risks. For Maine residents, the stakes are high: these injuries can be permanent, require multiple surgeries, and fundamentally alter quality of life.

As the litigation progresses, early bellwether trials are expected to set the stage for broader settlement discussions. Maine residents who have been injured should evaluate their claims now, before filing deadlines expire.

Maine legal landscape: Maine applies modified comparative fault with a 50% bar and follows strict liability for defective product claims. The state does not impose caps on punitive damages, though Maine courts require that punitive damages bear a reasonable relationship to compensatory damages. Residents in Portland, Lewiston, and Bangor and surrounding areas should consult with an attorney experienced in pharmaceutical litigation to evaluate their potential claim.

Filing Deadlines

Maine Statute of Limitations for GLP-1 Claims

The statute of limitations determines how long Maine residents have to file a GLP-1 injury lawsuit. In Maine, the product liability statute of limitations is 6 years, and the personal injury statute of limitations is 6 years.

Maine applies the discovery rule to pharmaceutical injury claims. This means the filing deadline may begin running from the date you discovered — or reasonably should have discovered — that your injury was caused by a GLP-1 medication, not the date you first took the drug. Because the link between GLP-1 medications and certain injuries is still emerging in the scientific literature, many Maine residents may have more time than they realize to file.

Every case is different. Factors such as when you were first prescribed the medication, when your injury was diagnosed, and when you became aware of the potential connection all affect your specific deadline. A free case review can help clarify your timeline.

Personal Injury SOL

6 years

Product Liability SOL

6 years

Discovery Rule

Yes

Eligibility

Do You Qualify in Maine?

Maine residents may be eligible to file a GLP-1 injury claim if the following apply:

Used a GLP-1 Medication

You were prescribed and used Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, Trulicity, or another GLP-1 receptor agonist medication while residing in Maine or another state.

Developed a Qualifying Injury

You were diagnosed with gastroparesis, vision loss (NAION), pancreatitis, gallbladder disease, or bowel obstruction after starting the medication.

Have Medical Documentation

You have medical records documenting your diagnosis. For gastroparesis claims, a gastric emptying study is strongly recommended but not required to begin the process.

Not Already Represented

You are not currently represented by another attorney for this specific claim. If you are unsure, your case review can help clarify.

Common Questions

Maine GLP-1 Lawsuit FAQ

What GLP-1 medications are involved in the Maine lawsuits?

The GLP-1 litigation covers several medications including Ozempic (semaglutide), Wegovy (semaglutide), Mounjaro (tirzepatide), Rybelsus (oral semaglutide), Saxenda (liraglutide), and Trulicity (dulaglutide). Maine residents who used any of these medications and suffered serious injuries may be eligible to file a claim. These drugs are manufactured by Novo Nordisk and Eli Lilly.

What is the statute of limitations for an Ozempic lawsuit in Maine?

In Maine, the statute of limitations for product liability claims is 6 years. Maine applies the discovery rule, which means the filing deadline may start from the date you discovered or should have discovered that your injury was caused by a GLP-1 medication, rather than the date you first took the drug. Given the evolving science around GLP-1 injuries, many residents may still have time to file.

What injuries qualify for a GLP-1 lawsuit in Maine?

Qualifying injuries include gastroparesis (stomach paralysis), vision loss caused by non-arteritic anterior ischemic optic neuropathy (NAION), pancreatitis, gallbladder disease requiring surgery, and bowel obstruction. All of these injuries must have developed after starting a GLP-1 medication. Maine residents who have experienced any of these conditions should seek a free case evaluation to determine eligibility.

How are GLP-1 lawsuit cases filed in Maine?

GLP-1 injury claims in Maine can be filed in state court through the Maine Superior Courts or in federal court. Many federal cases are being consolidated into multidistrict litigation (MDL 3094) for pretrial proceedings. The federal districts serving Maine include the District of Maine. An experienced attorney will determine the best venue for your specific case.

What compensation can Maine residents receive from a GLP-1 lawsuit?

Maine residents who qualify may recover compensation for medical expenses (hospitalization, surgery, ongoing treatment), lost wages and diminished earning capacity, pain and suffering, emotional distress, and diminished quality of life. The specific amount depends on the severity of your injury, required medical treatment, and impact on your daily life and ability to work.

Is there any cost to file a GLP-1 injury claim in Maine?

There is no upfront cost. Attorneys handling GLP-1 injury cases in Maine work on a contingency fee basis — they only get paid if you receive compensation. NuLegal's initial case review is completely free with no obligation to proceed. You will never be asked to pay out of pocket.

Maine Residents: Act Now

The product liability statute of limitations in Maine is 6 years. Get a free, no-obligation case review today to protect your rights and find out if you qualify for compensation.

Free Case Review

Advertisement

Disclosure: NuLegal operates as a legal referral service. Attorney Ashkaan Hassan evaluates claims and refers qualified cases to specialized trial firms, earning a referral fee from the attorney's share of any recovery. Clients never pay out of pocket.